Sign In
Buy VNRX
$2.08
-0.240 (-10.34%)
At Close: Jun 03, 2026
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing
08:30am, Tuesday, 09'th Jul 2024
HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaVentures Ltd ("PharmaVentures"), a leadi
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting
08:00am, Thursday, 27'th Jun 2024
HENDERSON, Nev. , June 27, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a mid-year review to stockholders, ahead of its
VolitionRx Limited to Present at Jefferies Global Healthcare Conference
08:00am, Wednesday, 29'th May 2024
HENDERSON, Nevada , May 29, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that Cameron Reynolds, President and Group
VolitionRx Limited (VNRX) Q1 2024 Earnings Call Transcript
08:24pm, Tuesday, 14'th May 2024
VolitionRx Limited (NYSE:VNRX ) Q1 2024 Results Conference Call May 14, 2024 8:30 AM ET Company Participants Cameron Reynolds - President, CEO Terig Hughes - CFO Andrew Retter - CMO Gael Forterre - CC
VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
04:10pm, Monday, 13'th May 2024
Conference call to discuss financial and operational results scheduled for Tuesday, May 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
08:00am, Wednesday, 08'th May 2024
Conference call to take place on Tuesday May 14 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
08:00am, Tuesday, 23'rd Apr 2024
HENDERSON, Nev. , April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® Vet Cancer Test is now avai
VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript
12:43pm, Tuesday, 26'th Mar 2024
VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
04:10pm, Monday, 25'th Mar 2024
Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
08:30am, Thursday, 21'st Mar 2024
Conference call to take place on Tuesday March 26 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
08:30am, Wednesday, 20'th Mar 2024
HENDERSON, Nev. , March 20, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has agreed a supply agreement with Fujifilm Vet Systems C
Volition appoints Dr Andrew Retter as Chief Medical Officer
04:30pm, Tuesday, 19'th Mar 2024
HENDERSON, Nev. , March 19, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr Andrew Retter as its Chief Medical Offic
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
08:00am, Friday, 02'nd Feb 2024
HENDERSON, Nev. , Feb. 2, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, to upd
Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances
04:54am, Thursday, 18'th Jan 2024
The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a recession,
VolitionRx has 'compelling plans' to advance veterinary care in 2024
09:41am, Thursday, 04'th Jan 2024
VolitionRx (NYSE-A:VNRX) has outlined its plans to advance its veterinary diagnostics platform after a successful 2023. Among the notable achievements in the past year, Volition successfully launched
